Pneumocystis jirovecii pneumonia prophylaxis in hematopoietic stem cell transplantation, is it acceptable to wait for the engraftment for restarting it?

Transplant Infectious Disease : an Official Journal of the Transplantation Society
Alessio MesiniElio Castagnola

Abstract

No abstract listed.

References

Nov 1, 1973·The Journal of Infectious Diseases·V Herbert
Nov 26, 2010·Bone Marrow Transplantation·A FontanetJ R Passweg
Apr 30, 2013·Emerging Infectious Diseases·Rishma MainiNick Phin
Nov 21, 2013·The Journal of Pediatrics·Désirée CaselliUNKNOWN Infectious Diseases Working Group of the Associazione Italiana Ematologia Oncologia Pediatrica
Aug 24, 2016·The Journal of Antimicrobial Chemotherapy·Johan MaertensUNKNOWN 5th European Conference on Infections in Leukaemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Tran
Jul 22, 2018·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Karen F UrbancicJason A Trubiano

❮ Previous
Next ❯

Citations

Dec 18, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Elio CastagnolaMaura Faraci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.